Sanofi once-weekly Altuviiio approved in Japan for hemophilia A Ruchika Sharma25 Sept 2023 5:01 PM ISTParis: Sanofi has announced that the Japanese Ministry of Health, Labor, and Welfare (MHLW) has granted marketing authorization for ALTUVIIIO...
Concizumab prophylaxis may reduce bleeding in patients of hemophilia A and B with inhibitors Dr. Shravani Dali2 Sept 2023 11:45 AM ISTConcizumab prophylaxis may reduce bleeding in patients of hemophilia A and B with inhibitors suggests a new study published in the New England Journal...
Moderna, Generation Bio ink pact to develop non-viral genetic medicines Ruchika Sharma26 March 2023 11:00 AM ISTGeneration Bio will receive a USD 40 million upfront cash payment and a USD 36 million equity investment issued at a premium over recent share prices.
Sanofi gets USFDA nod for hemophilia A treatment ALTUVIIIO Ruchika Sharma24 Feb 2023 12:19 PM ISTHemophilia A is a rare, lifelong condition in which the ability of a person's blood to clot properly is impaired, leading to excessive bleeds and...
Efanesoctocog Alfa prevents bleeding and improves QoL in patients with severe Hemophilia A: NEJM Medha Baranwal30 Jan 2023 10:45 AM ISTUSA: Once-weekly efanesoctocog alfa in patients with severe hemophilia A provides superior bleeding prevention to prestudy prophylaxis, according to...
Sanofi plans to unveil blood disorder drug this year: Report Ruchika Sharma20 Jan 2023 2:30 PM ISTFrance: French drugmaker Sanofi SA plans to launch a drug for rare bleeding disorder hemophilia A this year, Chief Executive Officer Paul Hudson told...
Novo Nordisk gets CDSCO Panel nod to study NN0365-3769 Dr. Divya Colin18 Dec 2022 5:00 PM ISTNew Delhi: In a significant development, the drug major Novo-Nordisk has got approval from the Subject Expert Committee (SEC) functional under the...
HemoRel-A safe in severe Hemophilia A Patients Dr. Nandita Mohan27 July 2022 10:00 AM ISTA recent study published in JAPI tried to evaluate efficacy for on-demand treatment of acute bleeding events, pharmacokinetics, safety, and...
Sanofi gets USFDA breakthrough therapy designation for hemophilia A drug Efanesoctocog alfa Ruchika Sharma2 Jun 2022 5:03 PM ISTHemophilia A occurs in about one in 5,000 male births annually, and more rarely in females.
Gene therapy found effective in Severe Hemophilia A in Phase 3 Study in Adults Dr. Kamal Kant Kohli15 Jan 2022 9:00 AM ISTSAN RAFAEL: A phase 3 study evaluating valoctocogene roxaparvovec, an investigational adeno-associated virus (AAV) gene therapy, in adults with severe...
Spontaneous scrotal hematoma as a sign of hemophilia A in a neonate: A BMJ report dr anusha24 May 2021 8:30 AM ISTLatest issue of British Medical Journal published the first reported case and youngest presentation of hemophilia as unilateral scrotal hematoma. ...
Turoctocog alfa new treatment option for hemophilia A patients: Study Dr. Nandita Mohan7 Nov 2020 11:22 AM ISTResearchers from the Department of Clinical Haematology, Haemato‐Oncology, & Bone Marrow (Stem Cell) Transplant Unit, Christian Medical College...
